Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GLAUKOS CORPORATION

(GKOS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société GLAUKOS CORPORATION
01/11GLAUKOS : Investor Presentation January 2022
PU
01/11GLAUKOS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
01/11Glaukos' iDose® TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Ov..
BU
01/11Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Dry Eye Disease
BU
01/11Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Presbyopia
BU
01/06Glaukos Announces FDA 510(k) Clearance of iPRIME™
BU
2021Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
BU
2021GLAUKOS : Announces Retirement of William J. Link, Ph.D., as Chairman of the Board and Ele..
PU
2021GLAUKOS CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financ..
AQ
2021Glaukos Announces Retirement of William J. Link, Ph.D., as Chairman of the Board and El..
BU
2021GLAUKOS : Investor Presentation November 2021
PU
2021GLAUKOS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2021Glaukos Announces Participation in Upcoming Investor Conferences
BU
2021Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Aca..
BU
2021GLAUKOS CORP Management's Discussion and Analysis of Financial Condition and Results o..
AQ
2021GLAUKOS : Q3 Earnings Snapshot
AQ
2021Glaukos Corporation Announces Third Quarter 2021 Financial Results - Form 8-K
PU
2021GAAP to Non-GAAP Reconciliation Tables – Q3 2021
PU
2021Glaukos Corporation Announces Third Quarter 2021 Financial Results
BU
2021Regulation FD Disclosure - Form 8-K
PU
2021GLAUKOS CORP : Regulation FD Disclosure (form 8-K)
AQ
2021GLAUKOS : Investor Presentation August 2021
PU
2021GLAUKOS CORPORATION : to Release Third Quarter 2021 Financial Results after Market Close o..
BU
2021GLAUKOS : Technologies Featured in Numerous Scientific Abstracts at the 2021 European Soci..
BU
2021GLAUKOS : Announces Licensing Agreement with Attillaps Holdings, Inc.
BU
2021GLAUKOS CORP : Other Events (form 8-K)
AQ
2021GLAUKOS : Announces Settlement of Patent Litigation with Ivantis, Inc.
BU
2021GLAUKOS : Announces Submission of Supplemental Pre-Market Approval Application for iStent ..
BU
2021GLAUKOS : Announces Participation in the Wells Fargo Healthcare Conference
BU
2021GLAUKOS : Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on..
BU
2021GLAUKOS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2021GLAUKOS : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
2021GLAUKOS : Q2 Earnings Snapshot
AQ
2021GLAUKOS CORPORATION : Announces Second Quarter 2021 Financial Results
BU
2021GLAUKOS : Technologies Featured in Numerous Scientific Abstracts at the 2021 American Soci..
BU
2021GLAUKOS CORP : Regulation FD Disclosure (form 8-K)
AQ
2021GLAUKOS CORPORATION : to Release Second Quarter 2021 Financial Results after Market Close ..
BU
2021GLAUKOS : Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Physici..
BU
2021GLAUKOS : Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. NDA Ph..
BU
2021GLAUKOS : Departure of Directors or Principal Officers; Election of Directors; Appointment..
PU
2021GLAUKOS CORP : Change in Directors or Principal Officers, Submission of Matters to a Vote ..
AQ
2021GLAUKOS : Announces Australia's TGA Regulatory Approval for PRESERFLO™ MicroShunt
BU
2021GLAUKOS : Announces Participation in the William Blair 41st Annual Growth Stock Conference
BU
2021GLAUKOS : Expands its PRESERFLO™ MicroShunt Relationship with Santen via New License..
BU
2021GLAUKOS : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
2021GLAUKOS : Q1 Earnings Snapshot
AQ
2021GLAUKOS : GAAP to Non-GAAP Reconciliation Tables – Q1 2021
PU
2021GLAUKOS CORPORATION : Announces First Quarter 2021 Financial Results
BU
2021GLAUKOS : Announces the Release of its 2020 Sustainability Report
BU
2021GLAUKOS : Announces Global Licensing Agreement Amendment with Intratus, Inc. to Include th..
BU
2021GLAUKOS CORPORATION : to Release First Quarter 2021 Financial Results after Market Close o..
BU
2021GLAUKOS : to Support World Glaucoma Week with Patient Education Campaign and Free Screenin..
BU
2021GLAUKOS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2021GLAUKOS : Announces Participation in Oppenheimer Healthcare Conference
BU
2021GLAUKOS CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financ..
AQ
2021GLAUKOS : Appoints Denice Torres and Dr. Leana Wen to its Board of Directors
BU
2021GLAUKOS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA..
AQ
2021GLAUKOS : 4Q Earnings Snapshot
AQ
2021GLAUKOS CORPORATION : Announces Fourth Quarter and Full Year 2020 Financial Results
BU
2021GLAUKOS : Announces Positive Phase 3 Trial Results for iLink™ Epi-on Investigational..
BU
2021GLAUKOS CORPORATION : to Release Fourth Quarter and Full Year 2020 Financial Results after..
BU
2021GLAUKOS : Looking Ahead To Avoid Spoliation Sanctions
AQ
2021GLAUKOS CORP : Results of Operations and Financial Condition, Regulation FD Disclosure, Fi..
AQ
2021GLAUKOS : Announces Preliminary, Unaudited Fourth Quarter and Full Year 2020 Net Sales
BU
2021GLAUKOS : rsquo; iDose® TR Demonstrates Sustained IOP Reduction and Favorable Safety Profi..
BU
2021GLAUKOS : U.S. IDE Trial Results for Glaukos' iStent infinite™ Show Substantial Redu..
BU
2020GLAUKOS : Announces Participation in J.P. Morgan Healthcare Conference
BU
2020GLAUKOS CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial ..
AQ
2020GLAUKOS : Announces Participation in Upcoming Investor Conferences
BU
2020GLAUKOS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2020GLAUKOS : 3Q Earnings Snapshot
AQ
2020GLAUKOS : GAAP to Non-GAAP Reconciliation Tables – Q3 2020
PU
2020GLAUKOS : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
2020GLAUKOS CORPORATION : Announces Third Quarter 2020 Financial Results
BU
2020GLAUKOS CORPORATION : to Release Third Quarter 2020 Financial Results after Market Close o..
BU
1  2  3  4Next
Upcoming event on GLAUKOS CORPORATION
03/02/22